This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Silvano Ronzoni: Innovator in Therapeutic Compounds
Introduction
Silvano Ronzoni is a notable inventor based in Baranzate di Bollate, Italy. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative work on morphinoid derivatives. His research has the potential to impact various medical conditions, showcasing the importance of his inventions in the healthcare sector.
Latest Patents
Ronzoni holds a patent for morphinoid compounds, specifically heterocycle condensed morphinoid derivatives. This patent highlights their therapeutic utility as analgesics, anti-allergic and anti-inflammatory agents, and brain cell protectants. These compounds are also relevant in treating conditions such as gastritis, diarrhea, cardiovascular and respiratory diseases, cough, mental illness, and epilepsy. Furthermore, they play a crucial role in the preservation of organs during transplant operations and in treating conditions typically managed with delta opioid receptor agonists. He has 1 patent to his name.
Career Highlights
Throughout his career, Silvano Ronzoni has focused on developing innovative solutions to complex medical challenges. His work has garnered attention for its potential applications in various therapeutic areas, demonstrating his commitment to advancing medical science.
Collaborations
Ronzoni has collaborated with notable professionals in his field, including Stephen Edward Clarke and Giulio Dondio. These partnerships have likely contributed to the depth and breadth of his research and innovations.
Conclusion
Silvano Ronzoni's contributions to the field of therapeutic compounds exemplify the impact of innovation in medicine. His work on morphinoid derivatives not only showcases his inventive spirit but also holds promise for improving patient care and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile